Zydus receives USFDA's final approval for Indomethacin Suppository with competitive generic therapy designation
Zydus' Indomethacin suppositories also been granted 180-day CGT exclusivity to market this product.
Zydus' Indomethacin suppositories also been granted 180-day CGT exclusivity to market this product.
JDHL has a strong reputation as an end-to-end design-focused manufacturer of electro-medical devices
Chintan Shivir has provided a platform to hold discussions with higher officials and experts, which will help in evolving better practices of premier health institutions like AIIMS
Marks the World Head & Neck Cancer Day at the OCTF Conference
CARA is a data and content management platform that helps companies in regulated industries such as finance, energy, and manufacturing transform their complex business processes
Erdafitinib is indicated for the treatment of adult patients with locally advanced or metastatic urothelial carcinoma
The CHMP’s recommendation will now be reviewed by the European Commission for marketing authorization in the European Union
KEYTRUDA plus concurrent chemoradiotherapy demonstrated statistically significant and clinically meaningful improvement in PFS versus concurrent chemoradiotherapy alone in these patients
CMOs showed an increasing reluctance to take on debt in 2022
The agreement extends the customer's suite of cloud DevOps, data engineering, and data platform management solutions
Subscribe To Our Newsletter & Stay Updated